Search - tctmd.com

June 17, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

February 14, 2025

News Daily News

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Todd Neale

September 25, 2024

News Daily News

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

May 20, 2024

News Daily News

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

March 12, 2024

News Daily News

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

February 28, 2024

News Daily News

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

December 11, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

June 30, 2023

News Daily News

CVD Risks After Pregnancy Linked to Prenatal Depression

April 21, 2023

News Daily News

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

November 25, 2022

News Daily News

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

October 27, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for September 26

Shelley Wood

September 26, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

April 19, 2022

News Daily News

Best Exercise for Heart Health? Some Hints of Intensity’s Role

December 02, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

October 11, 2021

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

August 17, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

February 11, 2021

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?